Minimally invasive surgical options took front and center in 2018 when the AUA published its revised guideline on the surgical management of male lower urinary tract symptoms secondary to BPH.
Convective radiofrequency water vapor thermal therapy (Rezum) can modestly improve symptoms of BPH, according to Daniel Mollengarden, MD.
Procedure safest when performed in <60 minutes.
A recent study found that sacral neuromodulation monotherapy was efficacious as a third-line treatment.
Nocturia appears to be highly prevalent in the United States, with almost 30% of all women reporting significant nocturia, according to new data reported at the AUA annual meeting in San Francisco.
Waking up at night to urinate is by far the most bothersome lower urinary tract symptom.
"When analyzing efficacy of minimally invasive/surgical therapies for lower urinary tract symptoms secondary to BPH, we appropriately focus on subjective criteria and objective criteria. While we discuss retreatment rates, we don’t measure failure of therapies by how many men restart LUTS/BPH medications," writes Steven A. Kaplan, MD.
Tissue-eliminating procedures outperform tissue-necrosing procedures for reducing the need for medication in patients with benign prostatic enlargement, researchers say.
The therapeutic efficacy of sacral neuromodulation was not affected by non-head magnetic resonance imaging scans in a recent study.
Over half of patients stop intradetrusor botulinum toxin injections within 10 years, mostly due to lack of clinical efficacy, researchers say.